Biologikatherapie nach COVID-19-Infektion: Keine Reaktivierung einer COVID-19-Infektion bei positivem Antikörperstatus SARS-CoV-2 unter Biologikatherapie

A case with rheumatoid arthritis and insufficient compensation under disease-modifying combined long-term therapy with methotrexate and leflunomide is reported. After recovery from a COVID-19 infection, a tumor necrosis factor (TNF) inhibitor therapy was initiated. Until now no reactivation of the C...

Descripción completa

Detalles Bibliográficos
Autores principales: Steinchen, N., Müller-Ladner, U., Lange, U.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Medizin 2020
Materias:
Kasuistiken
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7278764/
https://www.ncbi.nlm.nih.gov/pubmed/32514854
http://dx.doi.org/10.1007/s00393-020-00824-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7278764/
https://www.ncbi.nlm.nih.gov/pubmed/32514854
http://dx.doi.org/10.1007/s00393-020-00824-0

Ejemplares similares